| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |